Journal
NANOTOXICOLOGY
Volume 8, Issue 3, Pages 317-327Publisher
TAYLOR & FRANCIS LTD
DOI: 10.3109/17435390.2013.779757
Keywords
multi-walled carbon nanotube; surface modification; inflammasome activation; fibrosis; pulmonary toxicity
Categories
Funding
- NSF [CBET-0834233, EPS 1003907]
- NIH [1RC2ES018742-01]
- West Virginia University Research Corporation
- West Virginia EPSCoR Office
- [RC2 ES-018742]
Ask authors/readers for more resources
The current study tests the hypothesis that multi-walled carbon nanotubes (MWCNT) with different surface chemistries exhibit different bioactivity profiles in vivo. In addition, the study examined the potential contribution of the NLRP3 inflammasome in MWCNT-induced lung pathology. Unmodified (BMWCNT) and MWCNT that were surface functionalised with -COOH (FMWCNT), were instilled into C57BL/6 mice. The mice were then examined for biomarkers of inflammation and injury, as well as examined histologically for development of pulmonary disease as a function of dose and time. Biomarkers for pulmonary inflammation included cytokines, mediators and the presence of inflammatory cells (IL-1 beta, IL-18, IL-33, cathepsin B and neutrophils) and markers of injury (albumin and lactate dehydrogenase). The results show that surface modification by the addition of the -COOH group to the MWCNT, significantly reduced the bioactivity and pathogenicity. The results of this study also suggest that in vivo pathogenicity of the BMWCNT and FMWCNT correlates with activation of the NLRP3 inflammasome in the lung.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available